| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695764 | Gynecologic Oncology | 2017 | 5 Pages |
Abstract
For metastatic YWHAE-rearranged HG-ESS, prolonged disease control following diagnosis was seen, with notable responses to anthracycline-based therapy. This emphasizes the need for appropriate molecular testing of uterine mesenchymal malignancies and suggests that chemotherapy is an effective treatment option for metastatic YWHAE-rearranged HG-ESS.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Matthew L. Hemming, Andrew J. Wagner, Marisa R. Nucci, Sarah Chiang, Lu Wang, Martee L. Hensley, Suzanne George,